title: Successful treatment of refractory leiomyosarcoma with the PD-1 inhibitor nivolumab.
authors.affiliation: Medical Clinic III for Oncology, Hematology and Rheumatology.
authors.forename: A
authors.initials: A
authors.lastname: Heine
authors.affiliation: Insitute for Pathology.
authors.forename: G
authors.initials: G
authors.lastname: Kristiansen
authors.affiliation: Department for Radiology, University Hospital Bonn, Bonn, Germany.
authors.forename: H H
authors.initials: HH
authors.lastname: Schild
authors.affiliation: Medical Clinic III for Oncology, Hematology and Rheumatology peter.brossart@ukb.uni-bonn.de.
authors.forename: P
authors.initials: P
authors.lastname: Brossart
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm / Q000187:drug effects*; D006801:Humans; D007890:Leiomyosarcoma / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008297:Male; D000077594:Nivolumab; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D061026:Programmed Cell Death 1 Receptor; D000077594:Nivolumab